COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER UNE MALADIE NÉOVASCULAIRE, CONTENANT DU COLLAGÈNE DE TYPE I ET UN PEPTIDE DE FACTEUR DÉRIVÉ DE L'ÉPITHÉLIUM PIGMENTAIRE EN TANT QUE PRINCIPES ACTIFS
Inje University Industry-Academic Cooperation Foundation
发明人:
申请号：
EP18814409.1
公开号：
EP3636275A2
申请日:
2018.06.08
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating neovascular disease, comprising a collagen and a 34-mer pigment epithelium derived factor (PEDF) peptide as an active ingredient, more specifically, the combined administration of the collagen type I and the 34-mer pigment epithelium derived factor peptide increases the short antiangiogenic activity cycle of the PEDF and extends the dosage range of the PEDF to solve the discomfort and the side effects accordingly due to the conventional frequent injections and thus it can be applied as a therapeutic agent for various neovascular diseases.
